WHO ICTRP trial
A clinical trial to assess the safety, immune response, and protection against…
EUCTR2016-001265-92-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2016-001265-92-GB |
|---|---|
| Public title | A clinical trial to assess the safety, immune response, and protection against infection of novel malaria vaccines. |
| Scientific title | A Phase I/IIa Sporozoite Challenge Study to Assess the Safety and Protective Efficacy of adjuvanted R21 at different doses and the Combination Malaria Vaccine Candidate Regimen of adjuvanted R21 + ChAd63 and MVA encoding ME-TRAP. - A Safety and Efficacy Study of R21 + ChAd63/MVA ME-TRAP (VAC065) |
| Primary sponsor | University of Oxford, CTRG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Plasmodium falciparum infection;Therapeutic area: Diseases [C] - Parasitic Diseases [C03] |
| Interventions | Product Name: R21 Pharmaceutical Form: Solution for injection INN or Proposed INN: R21 Other descriptive name: R21c Concentration unit: µg microgram(s) Concentration type: equal Concentration number: 10-50 Concentration unit: µg… |
| Registration date | Jun 14, 2016 |
| Target size | 78 |
| Secondary IDs | VAC065 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: